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AbstrAct
Introduction Frailty is one of the most challenging 
aspects of population ageing due to its association 
with increased risk of poor health outcomes and quality 
of life. General practice provides an ideal setting for 
the prevention and management of frailty via the 
implementation of preventive measures such as early 
identification through screening.
Methods and analysis Our study will evaluate the 
feasibility, acceptability and diagnostic test accuracy of 
several screening instruments in diagnosing frailty among 
community-dwelling Australians aged 75+ years who 
have recently made an appointment to see their general 
practitioner (GP). We will recruit 240 participants across 2 
general practice sites within South Australia. We will invite 
eligible patients to participate and consent to the study 
via mail. Consenting participants will attend a screening 
appointment to undertake the index tests: 2 self-reported 
(Reported Edmonton Frail Scale and Kihon Checklist) 
and 5 (Frail Scale, Groningen Frailty Index, Program on 
Research for Integrating Services for the Maintenance 
of Autonomy (PRISMA-7), Edmonton Frail Scale and Gait 
Speed Test) administered by a practice nurse (a Registered 
Nurse working in general practice). We will randomise test 
order to reduce bias. Psychosocial measures will also be 
collected via questionnaire at the appointment. A blinded 
researcher will then administer two reference standards 
(the Frailty Phenotype and Adelaide Frailty Index). We will 
determine frailty by a cut-point of 3 of 5 criteria for the 
Phenotype and 9 of 42 items for the AFI. We will determine 
accuracy by analysis of sensitivity, specificity, predictive 
values and likelihood ratios. We will assess feasibility and 
acceptability by: 1) collecting data about the instruments 
prior to collection; 2) interviewing screeners after data 
collection; 3) conducting a pilot survey with a 10% sample 
of participants.
Ethics and dissemination The Torrens University Higher 
Research Ethics Committee has approved this study. We 
will disseminate findings via publication in peer-reviewed 
journals and presentation at relevant conferences.
IntroductIon
Background
Population ageing is proceeding at an 
unprecedented pace throughout the world,1 
with frailty among its most challenging 
manifestations.2 3 Frailty is associated with 
decreased quality of life,4–6 disability,4 5 7 8 
increased healthcare utilisation,4 5 7 9 falls,9 10 
institutionalisation9 11 and death.7 9 12 Despite 
the importance of frailty, there is currently 
no consensus regarding its prevalence.13 
One estimate based on a systematic review 
suggests a weighted average prevalence of 
10.7% among community-dwelling persons 
aged 65+ years, although results vary widely.13 
Applying even this conservative rate to the 
future Australian population aged 65+ years 
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Protocol
strengths and limitations of this study
 ► To the authors’ knowledge, this is among the first 
reported studies on frailty screening within the 
Australian general practice context.
 ► Our inclusion of feasibility and acceptability 
measures along with diagnostic test accuracy will 
strengthen the relevance of our study for policy and 
practice.
 ► The acceptability component of our study will 
measure acceptability of screening instruments to 
both health service providers (general practitioners 
and practice nurses) and consumers.
 ► This phase of the study will be limited to two general 
practice sites.
 ► The study will test only a subset of the full set of 
frailty screening instruments in international use 
due to inappropriateness for Australian context, 
excessive length or other exclusion criteria.
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would result in a projection of over 1 million frail Austra-
lians by 2061,14 a significant challenge for the healthcare 
system.
Geriatricians have traditionally provided specialist care 
for the frail. However, population ageing and the need 
for early identification, prevention and reversal of frailty 
highlights an increasing role for general practitioners 
(GPs) and healthcare teams in community settings as 
this population grows.15–17 Despite research advances, 
frailty research in primary care remains a ‘topic in its 
infancy’.16 Consequently, a growing number of studies 
have addressed the development and validation of frailty 
screening instruments in general practice settings—an 
issue especially relevant in Australia, where research on 
this topic has been limited.18 However, there remains 
much controversy over the validity and reliability of the 
instruments,19 20 leading to calls for more validation to 
be conducted across diverse populations. Furthermore, 
there remains extensive disagreement among the experts 
over how extensive screening should be.21–23 Regardless 
of the extent of screening, GPs and their teams will need 
accurate screening instruments to effectively identify 
those who are frail or at risk,24 25 and if translation into 
busy practices is to be successful, also instruments that 
are logistically feasible and acceptable to health service 
providers and consumers.
Australian care context and purpose for screening
In Australia, opportunities for comprehensive assess-
ment for older people in general practice through the 
75+ Health Assessment and associated care planning 
receive government rebates under the Medical Benefits 
Scheme (MBS).26 Through chronic disease and manage-
ment health plans, older people can then access rebated 
allied health (although limited) and psychology services. 
GPs are also able to refer to specialist geriatricians for 
Comprehensive Geriatric Assessment (CGA) for which 
also there is a specialist rebate. Access to medical services 
might vary by geographical region.
Means tested but publicly funded Aged Care Services 
that provide for home case support services and some 
therapy services are accessible through the centralised 
portal, My Aged Care. A brief assessment of multiple 
domains is undertaken but where care needs are iden-
tified as high, a more comprehensive assessment occurs 
through the Aged Care Assessment Programme. The 
older person might then be approved for more coordi-
nated in home care and support or residential aged care. 
Some service providers provide for day therapy services. 
At all times, older people are also able to access therapy 
and support services privately and when acute care is 
required, older people might access specialist geriatrics, 
rehabilitation and palliative care service through both 
the public and private hospital systems, although in some 
regions, these services might be limited.
Therefore, screening for frailty risk in general prac-
tice might allow the GP to identify earlier those aged 75 
years and older who might benefit from a comprehensive 
assessment via the 75+ Health Assessment, following 
which a management plan including further investigation 
and referral to various services might occur in a proactive 
rather than a reactive approach. The relative ‘safety net’ 
provided by the MBS-funded items has important impli-
cations for how we approach the issue of accuracy within 
this study. The most important consideration for Austra-
lian GPs is likely to be avoiding false negatives, so as to 
avoid missing people who actually are frail. In contrast, 
the consequences of false positives are less significant 
given the options for subsequent follow-up. We are thus 
emphasising sensitivity over specificity in our study.
Aside from accuracy, feasibility and acceptability 
will also be critical factors in the selection of screening 
instruments. The feasibility and acceptability of frailty 
screening instruments within general practice has been 
significantly under-researched.16 Consequently, we have 
drawn on several feasibility studies addressing the intro-
duction of non-frailty instruments in developing our 
approach,27 along with early results from focus groups 
on frailty conducted with Australian GPs. We will assess 
the feasibility and acceptability of the index tests from 
three perspectives: 1) feasibility of implementation within 
the context of a busy general practice environment; 2) 
acceptability to health service providers; 3) acceptability 
to consumers.
Within health research, passive case-finding (eg, using 
medical records) has been promoted as potentially 
advantageous over active case-finding due to lower cost 
and burden on study participants.28 It therefore could 
be viewed as a viable alternative to the active and rather 
intensive screening approach adopted in our study. 
However, passive case-finding is unviable within this 
context given that routinely collected medical records 
would be unlikely to capture the range of data required 
to detect frailty (with the possible exception of the 
construction of a frailty index) and are subject to high 
variability, a globally observed finding.28 These factors 
suggest an insufficiently reliable basis for its inclusion 
within our study.
In the absence of an Australian policy directive on 
frailty screening, screening will likely be directed to the 
most appropriate perceived candidates rather than to 
all persons of a given age. Preliminary findings from an 
aligned study of Australian GP perspectives on frailty 
and frailty screening29 indicate that in identifying poten-
tial candidates, it is probable that psychosocial factors 
may play a key role in GP considerations. For example, 
people who live alone, suffer depression or who have 
few social supports could potentially be at more risk 
from the impacts of frailty than those who have greater 
personal resources. The association of psychosocial 
factors with frailty is an emerging trend that has been 
reported within the research literature,30–35 although 
results to date have been mixed.36 Consequently, in 
order to better characterise those diagnosed as frail, we 
will also collect a range of psychosocial measures from 
our sample.
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Figure 1 Study flow diagram (diagnostic test accuracy component). GP, general practitioner.
objectives
Our study is designed to assess the (1) feasibility, (2) 
acceptability (to health service providers and consumers) 
and (3) diagnostic test accuracy of a number of frailty 
screening instruments within the context of Australian 
general practice. A fourth objective will be to explore 
the association of a range of psychosocial measures with 
frailty.
MEthods And AnAlysIs
We will employ a prospective, cross-sectional and obser-
vational research design. We have reviewed our study 
design against the Standards for Reporting of Diagnostic 
Accuracy and Quality Assessment of Diagnostic Accuracy 
Studies (QUADAS-2) criteria. The study will be conducted 
between July 2017 and June 2018.
setting
We will conduct the study within two general practice 
sites within South Australia, one metropolitan and one 
non-metropolitan. We will select practices based on 
purposive sampling.
Four practice nurses (registered nurses working in 
general practice)—two at each site—will be contracted to 
administer the index tests. Potential screeners will sign 
a consent form to enrol in the study. The screeners will 
attend training prior to commencement.
Participants
Eligibility
Inclusion criteria
We will employ convenience sampling to recruit our 
sample. Patients will be eligible if they were aged 75+ 
years as at 30th June 2016 and booked to attend at the 
study sites for an upcoming appointment over a prespeci-
fied period during 2017.
Patients with dementia will be included as participants 
if written, informed consent is given by a responsible 
person who is available to attend with them at the study 
sessions. Inclusion will be discussed on a case-by-case 
basis with the patient’s doctor. Doctors will cosign all 
consent forms involving patients with impaired ability to 
consent.
Exclusion criteria
We will exclude from the study those patients too ill to 
be assessed (ie, undergoing palliative care treatment or 
currently hospitalised), resident within residential care 
facilities or whose English is insufficient to fully partici-
pate.
substudy 1: diagnostic test accuracy
Data collection
Figure 1 outlines the overall data collection process for 
the diagnostic test accuracy aspect of the study.
Recruitment
We will mail eligible participants an invitation letter, 
consent form and participant information sheet. We will 
ask potential participants to sign a consent form (or if 
unable to consent, a family member will be asked to sign 
on their behalf) to be returned to the research team via 
self-addressed envelope. Participants will be given the 
right to withdraw from participation should they wish to, 
as well as to opt out of completing individual instruments. 
We will collect demographic information (age, sex) from 
those electing not to participate in order to compare 
participants with non-participants.
On receipt of the consent form, we will telephone 
the participant to make an appointment to attend the 
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screening session within 2 weeks to ensure information 
currency.
Recruitment will conclude on successful achievement 
of the required sample size (n=120 from each practice).
Screening session
On arrival, we will ask participants to complete a ques-
tionnaire including standard demographic information 
along with a select number of psychosocial instruments. 
They will then complete two self-reported index tests, 
returning each test as completed so that time to complete 
can be recorded. The practice nurse will then administer 
five administered index tests in random order. A blinded 
researcher (RA) will then administer the two reference 
standards. The total estimated duration of the appoint-
ment will be between 45 and 60 min.
Follow-Up
Where either of the reference standards indicates frailty, 
the participant will be offered a follow-up appointment 
with their GP. The research team will not collect data at 
this appointment.
test methods
Index tests: overview
Following a literature review, we shortlisted 14 frailty 
screening instruments as candidates for inclusion 
as index tests through discussion with the clinician 
members of the research team. We considered validity 
(sensitivity at least 0.6), appropriateness to context (in 
English, transferable to Australia) time to implement 
(≤20 min) and delivery method (administered, ie, not 
solely records-based) in our deliberations. We ultimately 
selected the following instruments for inclusion: FRAIL 
Screening Instrument; Groningen Frailty Index; Program 
on Research for Integrating Services for the Maintenance 
of Autonomy (PRISMA-7); Edmonton Frail Scale; Gait 
Speed; Reported Edmonton Frail Scale and Kihon Check-
list.
Index tests: administered by practice nurse
FRAIL Screening Instrument
The FRAIL Screening Instrument is a 5-item instrument 
addressing five aspects of frailty: fatigue, resistance, 
ambulation, illness and loss of weight.37 Each component 
is allocated one point and all components are summed, 
resulting in a scale from 0 to 5. The original cut-points 
will be used in this study and were: frail (3–5), prefrail 
(1–2) and robust (0) health status.
Groningen Frailty Indicator
The Groningen Frailty Indicator is a multidomain frailty 
instrument found to be reliable and valid in a Dutch 
community-dwelling population.38 39 It has 15 items, 
resulting in a summed score from 0 to 15, with the frailty 
cut-point—also used in this study—set at 4 or more points.
 PRISMA-7
The PRISMA-7 is a screening instrument validated in 
a community-dwelling population aged 75 years and 
older.40 It consists of a set of seven yes/no questions. 
Previous research indicates high sensitivity but limited 
specificity in identifying frailty.41 In the original formula-
tion, also used in this study, three or more ‘yes’ responses 
indicated frailty.40
Edmonton Frail Scale
The Edmonton Frail Scale (EFS) is a measure developed 
and validated on a community-dwelling population aged 
65+ years.42 Scored from 0 to 17, it measures frailty across 
ten domains including cognition, social support, medica-
tion use and functional performance. The original study 
does not provide a specification for frailty cut-point; this 
study will consequently follow previous studies in adopting 
a cut-point of 8 or more points to define frailty.43 44
Gait speed
Gait speed is a reliable and valid measure widely applied 
within the research literature.45 46 It has been found to 
have high sensitivity (but limited specificity) in identi-
fying frailty.41 Following the recommendations of Castell 
et al and the wide application of this cut-off point in prac-
tice,46 we will apply a ≤0.8 m/s cut-off point for frailty in 
our study.
Index tests: self-reported
Reported Edmonton Frail Scale
The Reported Edmonton Frail Scale is a self-reported 
version of the Edmonton Frail Scale.44 The resultant 
scale ranges from 0 to 18 with the following cut-points 
defined: ‘not frail’ (0–5), ‘apparently vulnerable’ (6–7), 
‘mild frailty’ (8–9), ‘moderate frailty’ (10–11) and ‘severe 
frailty’ (12–18). We will apply the original reported 
cut-point of 8 or more in our study.
The Kihon Checklist
The Kihon Checklist is reported to be a reliable self-re-
ported instrument for predicting frailty in older adults.47 
It consists of 25 yes/no questions covering a range of 
domains. We will replicate the frailty cut-point reported 
in Sewo Sampaio et al48 of a total of seven or more ‘yes’ 
questions.
Reference standards
We consulted prior research for potential reference stan-
dards, identifying three commonly used candidates25 41: 
CGA, the Frailty Phenotype (based on the Cardiovascular 
Health Study definition7) and Frailty Index (based on the 
Canadian Study of Health and Aging49).
The CGA, an interdisciplinary diagnostic procedure 
aiming to identify a range of issues in older people, is 
commonly thought to be the gold standard for frailty iden-
tification.25 However, its time-consuming and resource 
intensive nature,41 50 makes it beyond the scope of imple-
mentation as a reference standard within our study.
The alternatives—the Frailty Phenotype and Frailty 
Index—have admittedly been labelled as ‘different 
instruments for different purposes’,51 due largely to the 
inclusion of disability items in the Frailty Index versus the 
Phenotype. Our inclusion of both as reference standards 
might therefore be seen as controversial, if not for the 
fact that the version of the Frailty Index we will apply in 
this study explicitly excludes disability items.
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Table 1 Fried cut-off criteria for frailty (grip strength)
Men Women
BMI Cut-off (kg) BMI Cut-off (kg)
≤24 ≤29 ≤23 ≤17
24.1–26 ≤30 23.1–26 ≤17.3
26.1–28 ≤30 26.1–29 ≤18
>28 ≤32 >29 ≤21
BMI; body mass index.
The remaining differences between the two standards 
mainly relate to the feasibility of applying them within 
general practice, a factor that does not apply here given 
their use as reference standards rather than index tests. 
Additionally, the risk of differential verification bias, 
present when not all test subjects undertake both refer-
ence standards,52 is not expected to impact our study as 
all participants will undertake both reference standards 
equally. Results for both standards will be presented, 
along with a detailed analysis of cases varying between the 
two.
We contend that our decision to include both refer-
ence standards offers a significant contribution to the 
frailty evidence base, given we are operating with an 
absence of consensus about which reference standard is 
superior. Including both reference standards will ensure 
our research remains relevant into the future, regardless 
of subsequent changes in expert opinion. Given we are 
still at an early stage of our understanding about frailty 
screening within Australia, we maintain that in this 
instance, more information will ultimately prove better 
than less.
Frailty Phenotype
The Frailty Phenotype has received broad acceptance 
worldwide,46 having been externally validated within 
several large epidemiological studies.41 53 Recognised 
drawbacks include its lack of cognitive and psychosocial 
domains,33 however, it has predicted significant nega-
tive health-related outcomes across numerous studies to 
date.33 54
This study will implement original formulation by Fried 
et al, as shown below [7:M156].
 ► Shrinking (unintentional weight loss of ≥10 pounds in 
the prior year or, at follow-up, of ≥5% of body weight 
in the prior year by direct measurement of weight), as 
assessed by the question: "n the last year, have you lost 
more than 10 pounds unintentionally (ie, not due to dieting 
or exercise)?”
 ► Weakness: we will measure grip strength with a hand-
held Jamar dynamometer, assessing maximal grip 
strength (kg) in the dominant hand (average of three 
measures). Fried’s cut-points are shown in table 1 and 
will be used in this study.
 ► Poor endurance and energy: indicated by self-reported 
exhaustion based on the Center for Epidemiological 
Studies-Depression (CES-D) scale.55 The frailty 
criterion is satisfied if the participant response is ‘a 
moderate amount’ or ‘most of the time’ in answer to 
the following:
 ► (a) "I felt that everything I did was an effort."
 ► (b) "I could not get going."
 ► Slowness: measured by gait speed (time taken to walk 
15 feet). We will employ the cutoffs reported in Fried et 
al: ≥7 s (men of height ≤173 cm and women ≤159 cm), 
and ≥6 s (men of height >173 cm and women >159 cm).
 ► Low physical activity level: measured by the short-form 
Minnesota Leisure Time Activity questionnaire.56 The 
questionnaire is used to derive a weighted score of 
kilocalories expended/week, with the following cut-
points: men <383 and women <270 kcals/week.
The frailty cut-points specified in the original model 
and used within this study were that three or more compo-
nents meeting the criteria indicate frailty.
Adelaide Frailty Index
The second reference standard is the Adelaide Frailty 
Index (AFI), a 42-item variant of a standard frailty index 
based on the methodology reported by Searle et al.57 It was 
developed by Mark Thompson as part of ongoing work 
within the regional geriatric health service (Thompson et 
al, unpublished).58 The frailty cut-point for the AFI, also 
applied within this study, is a score of 9 or more (ie, 21% 
or more).
The AFI includes elements drawn from the following 
frailty risk factors: shrinking, exhaustion, low energy 
expenditure, slowness, weakness, cognitive impairment, 
falls and balance, urinary incontinence, polypharmacy, 
oral health, pain, mental health and chronic conditions. 
Several questions within the AFI were derived from vali-
dated screening instruments in common use within those 
domains. The AFI intentionally excludes disability items, 
in recognition of the distinction between disability and 
frailty.59
Psychosocial instruments
In recognition of the complex relationship between 
psychosocial factors and frailty, we will administer five 
psychosocial instruments within the self-complete ques-
tionnaire. Depression is associated with frailty among older 
people34 and is measured here via the commonly used 
Geriatric Depression Scale-15.60 Social isolation will be 
measured by an abbreviated version of the Lubben Social 
Network Scale-6, which has been widely used worldwide 
to measure isolation among older people.61 62 A measure 
relating to sense of perceived control, as originally 
conceptualised and validated by Lachman and Weaver,63 
has previously been demonstrated to play a mediating 
role with respect to frailty35 and will be included within 
the set. Likewise, negative self-perceptions of ageing have 
been found to have a modifying effect on frailty64 and 
will be included in the form of the Brief Ageing Percep-
tions Questionnaire.65 Lastly, a specific measure of older 
people’s quality of life will be measured using the ICEpop 
CAPability measure for Older people (ICECAP-O).66
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Other measures
In addition to the index tests collected at the screening 
appointment, the practice nurse will also collect the 
Nottingham Extended ADL scale (NEADL).67 The 
NEADL is a valid and reliable measure of functioning that 
has been widely applied among older populations.68
data management
We will collect data manually, verifying it where required 
against clinical records. We will identify participants by 
a unique identifier, with linkage keys to be stored sepa-
rately from the data. Data will be entered into an SPSS 
database. We will subject 5% of the records to a random 
audit by a second researcher to test data quality. We will 
store all deidentified study data on a password-protected 
drive.
statistical methods
Sample size
We derived a sample size estimate using a methodology 
reported by Buderer incorporating consideration of 
disease prevalence.69 This calculation was complicated 
by the absence of a reliable Australian frailty prevalence 
rate, so we drew on a number of community-based studies 
to derive a prevalence estimate. Two Australian studies 
suggested frailty prevalence rates of 25% for the 75+ and 
17.5% for the 70+ (Thompson et al, unpublished data 
and Widagdo et al18), and a Spanish study reported a 19% 
prevalence among the 75+.46 Ultimately, we selected a 
20% prevalence rate as a conservative choice, applying 
this figure within Buderer’s formula along with sensitivity 
of 90% and specificity of 60%. The clinically acceptable 
width of the 95% CIs for sensitivity and specificity was 
set to be no larger than 10, giving a minimum estimated 
sample size of 173 persons. We will aim to recruit at least 
240 participants. This allows for a buffer of 25% above 
the minimum sample to address attrition in the short 
period between consent and attendance at the screening 
appointment while also allowing for the possibility of a 
lower than estimated prevalence of frailty in the popula-
tion.
Analysis
We will examine the distribution of quantitative variables 
visually and by using the Shapiro-Wilk test for normality.70 
Categorical variables will be described as frequencies. 
Quantitative variables will be displayed as mean±SD, 
where normally distributed or as medians with 25th and 
75th percentiles were asymmetrically distributed. Where 
the results for an index test or reference standard are 
indeterminate or incomplete, results for that participant 
will be excluded. No imputation will be performed for 
missing data.
Our accuracy analysis will compare the results of each 
index test against each reference standard. We will 
construct variables reflecting each frailty instrument and 
define the presence of frailty according to the specified 
cut-points. We will create standard 2×2 tables for each 
index test against each reference standard, and calcu-
late sensitivity and specificity with their corresponding 
95% CIs, along with positive and negative predictive 
values and likelihood ratios. We will determine the extent 
of agreement between the index tests and reference stan-
dards by calculating Cohen’s kappa.
To analyse the relationship between the psychosocial 
variables and frailty, we will define the presence of frailty 
as a binary variable (frail/not frail) according to the 
Fried criteria as measured in the Frailty Phenotype. We 
will use binomial (binary) logistic regression to analyse 
the association strength (OR) for the frail state with the 
psychosocial variables using the non-frail state as the 
comparison category. We will consider a p value of <0.05 to 
be statistically significant. The data will be analysed using 
the latest available version of the SPSS statistical software 
(version 24.0 SPSS, Chicago, Illinois, USA).
To test inter-rater reliability, 8 subjects tested by each 
screener (32 in all) will be asked to repeat the index test 
session including self-reported tests with a second blinded 
screener within 48 hours after the initial rating. Given 
the binary nature of the outcome (ie, frail/not frail) 
and multiple raters, the kappa coefficient will be used to 
ascertain agreement, with the minimum acceptable value 
set to 0.6. We will ask every third participant participating 
at each research site in the main study to participate in 
the inter-rater reliability component, proceeding until 
such time as the site and screener quota is reached.
substudy 2: feasibility and acceptability
We will apply a convergent parallel mixed methods 
approach to the analysis of feasibility and acceptability. 
We define mixed methods research, following Johnson et 
al, as a type of research combining ‘elements of qualita-
tive and quantitative research approaches … for the broad 
purposes of breadth and depth of understanding and 
corroboration’ (Johnson et al, p. 123).71 Mixed methods 
have increasingly been applied within the health sciences 
in recent years, where a more complete understanding 
of an issue is allowed than by a quantitative or qualitative 
approach alone.72
data collection and management
Feasibility
We will measure the feasibility of the index tests by 
collecting the following information about each test:
Noted by research team prior to data collection
 ► Education or training required to administer each test
 ► Special equipment/devices required
 ► Physical space required
Collected by practice nurse during session
 ► Time to administer each instrument
 ► Instrument completion by respondents (include any 
reasons for non-completion)
Acceptability to health service providers
We will ask the screeners to complete a standardised form 
to capture initial impressions of the instruments during 
the data collection period. We will also request that 
screeners participate in an interview conducted within 
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a week after data collection has concluded to gather 
their overall impressions of the instruments. We will rate 
each instrument against a 1–10 Likert scale measuring 
ease of implementation as well as including a number of 
open-ended questions. We will ask screeners to rank the 
instruments in order of preference.
Acceptability to consumers
We will pilot an acceptability questionnaire with 26 partic-
ipants during data collection (13 to be recruited from 
each research site, respectively). This figure represents 
just over a 10% sample of participants, as well as exceeding 
the n=25 threshold recommended by Herzog in her 
discussion of appropriate sample sizes for aims related to 
instrumentation.73 We will ask every second participant 
participating at each research site in the main study to 
participate in the acceptability component. Sampling will 
proceed until the site quota is reached.
After applying each index test the screener will ask partic-
ipants their impressions of the instrument and record 
the response. We will also ask participants to complete a 
1–10 Likert-scale questionnaire measuring perceived ease 
in completing each instrument. In addition, screeners 
will collect refusal rates from all respondents, including 
reason for refusal.
Data management
Separate variables will be developed in SPSS to represent 
each numerical data measure. We will record and tran-
scribe the screener interviews, uploading the transcripts 
to the NVivo software package. We will also store and 
analyse comments reflecting impressions of the instru-
ments within NVivo. Otherwise, we will follow similar 
data security and deidentification procedures as specified 
under Diagnostic Accuracy.
data analysis
Feasibility
We will use descriptive statistics and tables to describe 
the results of the feasibility analysis, structuring these 
according to themes drawn out in our early focus groups.
Acceptability to health service providers
Two researchers will employ a thematic analysis approach 
to code the data contained within the screener transcripts. 
We will use these codes to develop acceptability categories 
and themes. Codes and themes will be reviewed with a 
third researcher experienced in qualitative methodology 
to promote rigour.
We will create joint displays (ie, side-by-side comparison 
tables) of ranking results for the screening instruments 
and qualitative comments about screener impressions of 
the instruments to facilitate data integration.
Acceptability to consumers
We will present consumer ratings for each instrument 
(Likert scale) as frequency tables, along with reporting 
the mean, range and proportion in each group. We will 
use a joint display to add indicative qualitative comments 
about these results, aiming to represent the range of 
opinion for each instrument. Against each instrument, 
we will also present summary descriptive data based on 
the whole sample describing refusal rates and reason for 
refusal.
Interpretation
We will structure our discussion of the results by each 
dimension of feasibility/acceptability, noting the extent 
of convergence between the qualitative and quantita-
tive data sources where appropriate. Where divergence 
occurs, we will discuss potential causes and implications.
EthIcs And dIssEMInAtIon
Ethics and informed consent
The study has been approved by the Torrens University 
Higher Research Ethics Committee. Written informed 
consent will be obtained from all participants and 
screeners prior to participation. Where informed consent 
cannot be obtained due to cognitive impairment, consent 
will be sought from an attendant person responsible for 
the participant and cosigned by the GP.
Participant safety
At each site the health service provider will do a brief 
safety analysis prior to commencement to ensure it is safe 
to proceed. We will offer participants the right to refuse 
participation in physical tests they deem unsafe. Where 
participants are unable to complete their appointment 
due to fatigue, we will offer them the option to attend a 
separate session within the following 48 hours in order to 
complete data collection.
dissemination
We will publish our findings within peer-reviewed jour-
nals and present at relevant conferences within the field. 
Separate publications will address findings for the diag-
nostic test accuracy and psychosocial research objectives. 
At no time will participants be identifiable within the 
research dissemination process.
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